Special Issue: COVID-19


Manuscripts describing original research (full length or short research communications), review articles, genome reports, and protocols and methods in virology and cellular biology as well as engineering and information technology leading to improving the understanding of mechanism(s) of infection and to the development of tools for tracing, tracking and applications in infection control of Corona Virus Infectious Disease-19 (COVID-19) are invited from experienced researchers for a Special Issue to be published in 3Biotech.

Publication of articles:

3 Biotech publishes manuscripts under Continuous Article Publishing (CAP) in which accepted papers are published online with volume and article numbers shortly after receipt of authors proofs. CAP aims to speed up the process from acceptance to final publication of articles without the need for articles to be placed in a waiting queue. This will ensure that all articles in 3 Biotech are immediately available to readers and researchers and in the indexing and abstracting databases.

Instruction for authors

Follow these guidelines to prepare your manuscript.

During the submission process, the special issue “COVID-19” is available in the drop down under “Additional Information”.

Important Dates:

Submission date:       1 May 2020
Closing date:              31 December 2020


Bharat Patel, Executive Editor in Chief (3 Biotech)
Queensland University of Technology, Brisbane, Australia
Email: bharat.patel@qut.edu.au; bharatgu19@gmail.com

Guest Editors:

Saad Motahhir, ENSA, Sidi Mohamed Ben Abdellah University, Fez, Morocco

Umashankar Subramanium, Prince Sultan University, Riyadh, Saudi Arabia (Engineering and IT)

Shailendra K. Saxena, King George's Medical University (KGMU), Lucknow, India (Medical Virology)

Rachid El Fatimy, Mohammed VI Polytechnic University, Ben Guerir, Morocco & Harvard Medical School, Boston, USA (Neurology)